Invention Grant
- Patent Title: Chimeric peptide that interacts with cell membrane gangliosides
-
Application No.: US15125237Application Date: 2015-03-10
-
Publication No.: US10087226B2Publication Date: 2018-10-02
- Inventor: Jacques Fantini , Nouara Yahi
- Applicant: Universite D'Aix-Marseille
- Applicant Address: FR Marseilles
- Assignee: Universite D'Aix-Marseille
- Current Assignee: Universite D'Aix-Marseille
- Current Assignee Address: FR Marseilles
- Agency: Cesari and McKenna, LLP
- Priority: EP14305353 20140311
- International Application: PCT/EP2015/054968 WO 20150310
- International Announcement: WO2015/135942 WO 20150917
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K38/00
Abstract:
The invention relates to a chimeric peptide displaying the ganglioside-binding properties of both α-synuclein and β-amyloid peptide. Such peptide is useful in preventing or treating any condition which involves gangliosides as cell surface receptor sites, including neurodegenerative disorders, infectious diseases, or tumors.
Public/Granted literature
- US20170073383A1 A CHIMERIC PEPTIDE THAT INTERACTS WITH CELL MEMBRANE GANGLIOSIDES Public/Granted day:2017-03-16
Information query
